We’ve teamed up with Piff Advisor to run a series on ISMOKE about the many medicinal benefits of cannabis, and this week the focus is on Cannabis for Crohns Disease.
It’s great to tell people that cannabis is a Medicine, but sometimes it’s hard to back yourself up without having some proper evidence available to support the cause.
Here are just some of the studies into cannabis for Crohns Disease that show the medicinal benefits it has:
Study Name: Efficacy, Tolerability, And Safety Of Cannabinoids In Gastroenterology : A Systematic Review
Findings: Cannabis may be useful for symptom relief in Crohn’s disease such as pain, nausea, and loss of appetite.
Study Name: Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation.
Findings: Treatments with FAAH-II improved overall clinical scores by reversing weight loss and colitis-associated pathogenesis
Study Name: Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study.
Findings: Five of eleven patients receiving THC went into complete remission. All patients receiving cannabis reported improved appetite and sleep, with no significant side effects
Study name: The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn’s disease.
Findings: The endocannabinoid system may influence the manifestation of inflammatory bowel diseases, suggesting endocannabinoids as potential target for future therapies.
Piff Advisor will provide its users with access to over 500 different studies into cannabis and its medicinal properties.
Their website will be launching soon at www.piffadvisor.com and we will be attending their secret launch party this year.
What medicinal cannabis properties would you like us to cover in the future? Let us know by emailing firstname.lastname@example.org or tweet us @ISMOKEMAG